Development by New Orleans biotech company to enable studies of human fat tissue in vitro

Harvard’s ARMMs technology to be commercialized by Vesigen Therapeutics for targeted intracellular delivery of large-molecule drugs

Medical device company will pursue development of strong, biocompatible adhesive that could replace sutures and dental membranes

Islet-on-a-chip technology streamlines diabetes research